Medipixel

We Heal the World in a New Way

Seoul, South Korea · Founded 2017 · $21.0M raised

Headquarters
Seoul
Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$21.0M
Last Round
$13.0M Series BOct 2023
Rounds
2

About

Medipixel is a South Korean MedTech company founded in 2017 that develops AI-powered diagnostic and therapeutic solutions for cardiovascular and neurovascular intervention procedures. The company's flagship products — MPXA and MPNeuro — leverage deep learning to provide real-time analysis and guidance during coronary and cerebral artery interventions, enabling faster and more accurate clinical decision-making. Medipixel serves hospitals and interventional cardiologists, holding numerous patents and partnering with leading medical institutions globally as it expands beyond cardiovascular into broader neurovascular applications.

Summary

Medipixel is an Artificial Intelligence company based in Seoul, South Korea, founded in 2017. It has raised $21.0M in total across 2 rounds, most recently a $13.0M Series B round in Oct 2023. Investors include Premier Inc., Mirae Asset and SBI Investment Korea.

Tech & App Stack

3 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BOct 2023
$13.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies